Overview

This trial is active, not recruiting.

Condition habitual abortion
Sponsor Ankara Education and Research Hospital
Trial identifier NCT01644318, 3848

Summary

The purpose of this study is to measure serum CXCL9 and CXCL11 levels in patients with autoimmune thyroiditis and habitual abortions

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case control
Time perspective cross-sectional
Arm

Primary Outcomes

Measure
Serum CXCL9 and CXCL11 levels in patients with autoimmune thyroiditis and habitual abortions
time frame:

Eligibility Criteria

Female participants from 20 years up to 40 years old.

Inclusion Criteria: - non-pregnant women with euthyroid autoimmune thyroiditis and a history of first trimester recurrent spontaneous abortions Exclusion Criteria: - 1) presence of acute or chronic systemic diseases; 2) other autoimmune diseases; 3) pregnancy and lactation over the previous 6 months; 4) evidence of infectious diseases in the last 3 months; 5) treatment with drugs known to interfere with cytokine release, such as corticosteroids, immunosuppressors, or nonsteroidal antiinflammatory drugs, amiodarone, and lithium; 6) clinical history of hyperthyroidism and/or the presence of anti-TSH receptor antibodies.

Trial information was received from ClinicalTrials.gov and was last updated in July 2012.
Information provided to ClinicalTrials.gov by Ankara Education and Research Hospital.